Consilient Health Ltd.
https://www.consilienthealth.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Consilient Health Ltd.
Deal Watch: Vertex Calls On CRISPR Yet Again, Now To Collaborate On Type 1 Diabetes
Vertex and CRISPR look beyond beta thalassemia and sickle cell disease. Also, Bicycle gets $50m up front in Novartis deal, Regeneron commits $75m initially under a Treg collaboration with Sonoma, and Jounce gets a better deal from Concentra to wave off Redx merger.
Deal Watch: Merck & Co. Looks To Advance NASH Ambitions With Aligos
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
Major Milestone For Diurnal As FDA Approves Alkindi
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.
Company Information
- Industry
-
Services
- Group Purchasing
- Home Infusion
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice